Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PROP1 | hg19_v2_chr5_-_177423243_177423243 | 0.21 | 3.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_92371839 Show fit | 2.55 |
ENST00000370399.2
|
transforming growth factor, beta receptor III |
|
chr6_+_116691001 Show fit | 1.20 |
ENST00000537543.1
|
dermatan sulfate epimerase |
|
chr16_+_68119247 Show fit | 1.07 |
ENST00000575270.1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
chr6_-_76072719 Show fit | 1.06 |
ENST00000370020.1
|
filamin A interacting protein 1 |
|
chr3_-_18480260 Show fit | 0.89 |
ENST00000454909.2
|
SATB homeobox 1 |
|
chr16_+_68119324 Show fit | 0.81 |
ENST00000349223.5
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
chr8_-_93107443 Show fit | 0.81 |
ENST00000360348.2
ENST00000520428.1 ENST00000518992.1 ENST00000520556.1 ENST00000518317.1 ENST00000521319.1 ENST00000521375.1 ENST00000518449.1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
|
chr15_-_52970820 Show fit | 0.79 |
ENST00000261844.7
ENST00000399202.4 ENST00000562135.1 |
family with sequence similarity 214, member A |
|
chr1_+_84630645 Show fit | 0.76 |
ENST00000394839.2
|
protein kinase, cAMP-dependent, catalytic, beta |
|
chr16_+_68119440 Show fit | 0.74 |
ENST00000346183.3
ENST00000329524.4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 2.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 1.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 1.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 0.8 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.1 | 0.8 | GO:0097338 | response to clozapine(GO:0097338) |
0.2 | 0.7 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.0 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 2.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 0.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 1.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.7 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.6 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 2.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |